Introduction
The vancomycin-type glycopeptides are the drugs of last resort for the treatment of severe infections caused by antibiotic-resistant Gram-positive bacteria, in particular by methicillin-resistant staphylococci and penicillin-resistant enterococci [Yao and Crandall, 1994] . Balhimycin ( fig. 1 b) , a vancomycin-like glycopeptide antibiotic which is synthesized by Amycolatopsis balhimycina (formerly Amycolatopsis mediterranei ) DSM5908 [Nadkarni et al., 1994; Wink et al., 2003] , shares the same heptapeptide aglycon as vancomycin ( fig. 1 a) , but differs in the glycosylation pattern. The activity of glycopeptide antibiotics against a wide range of Gram-positive bacteria arises from their ability to bind to the terminal D -alanyl-D -alanine ( D -Ala-D -Ala) dipeptide of bacterial cell wall precursors [Williams and Bardsley, 1999] .
Recent advances in the investigation of balhimycin biosynthesis by means of genetics and biochemistry, as well as analytical chemistry of the pathway intermediates, rendered an understanding of the central steps of the glycopeptide biosynthesis (as reviewed by Stegmann et al. [2005] ). Starting with the supply of the non-proteinogenic amino acid precursors, followed by the assembly of the heptapeptide scaffold, and finally by a series of modifying reactions, balhimycin displays a great structural complexity. All genes required for its biosynthesis are clustered [Pelzer et al., 1999; Recktenwald et al., 2002] .
However, comparison with other glycopeptide biosynthesis gene clusters coding for chloroeremomycin [van Wageningen et al., 1998 ], teicoplanin [Li et al., 2004; Sosio et al., 2004] , dalbavancin [Sosio et al., 2003 ], complestatin [Chiu et al., 2001] and A47934 [Pootoolal et al., 2002] revealed that resistance, transport and regulatory genes are still missing from the sequence of the balhimycin biosynthesis gene cluster determined so far.
In particular, the identification and characterization of regulatory genes is crucial for understanding the mechanism by which complex biosynthetic steps are coordinated and for genetically manipulating the producing strains to enhance antibiotic production.
Regulation of secondary metabolism is governed mainly by pathway-specific regulators. Many of the pathway-specific regulatory proteins that control secondary metabolism in streptomycetes belong to the SARP ( Streptomyces antibiotic regulatory proteins) family. These transcriptional activators contain a winged helix-turnhelix (HTH) motif towards their N-termini that is also found in the OmpR family of proteins and at least some of the SARPs appear to recognize direct heptameric repeats within the promoter regions of the genes that they regulate [Wietzorrek and Bibb, 1997] . SARPs include ActII-ORF4 from Streptomyces coelicolor A3(2), DnrI from Streptomyces peucetius , which regulate the production of the polyketide antibiotics actinorhodin and daunorubicin, respectively, RedD from S. coelicolor A3(2), which controls synthesis of the tri-pyrolle undecylprodigiosin, and AfsR, a pleiotropic regulatory protein for antibiotic production in S. coelicolor A3(2) [Arias et al., 1999; Sheldon et al., 2002; Wietzorrek and Bibb, 1997] .
Besides SARPs, other types of pathway-specific regulators have been identified in different Streptomyces
strains: such as SrmR of the spiramycin cluster in Streptomyces ambofaciens , which shows no significant sequence similarity to any other known regulatory protein; MmyR of the methylenomycin cluster in S. coelicolor , representing the first example of a negative pathway-specific regulator of antibiotic production [as reviewed by Chater and Bibb, 1997] , PrpA of the phosphinothricin tripeptide cluster in Streptomyces viridochromogenes [Schwartz et al., 2004] , BrpA and DnrN regulators for bialaphos production in Streptomyces hygroscopicus and for daunorubicin production in Streptomyces peucetius, respectively, which are similar to two-component response regulators [as reviewed by Chater and Bibb, 1997] and TylP from Streptomyces fradiae which negatively regulates tylosin production [Stratigopoulos et al., 2002] and is homologous to ␥ -butyrolactone-binding proteins.
Another type of regulator is exemplified by StrR, the pathway-specific activator protein in Streptomyces griseus [Retzlaff and Distler, 1995] and Streptomyces glausescens [Beyer et al., 1996] . It activates the expression of streptomycin biosynthetic genes by binding to several promoter regions. Based on seven specific binding sites, a consensus sequence GTTCGActG(N) 11 CagTcGAAC [Retzlaff and Distler, 1995] was deduced. Transcription of all the streptomycin biosynthesis genes apart from the resistant gene is dependent on StrR as shown by Tomono et al. [2005] . StrR has a putative HTH motif in the central region of its primary structure [Retzlaff and Distler, 1995] . Homologs of strR have been found in aminocoumarin, aminoglycoside and glycopeptide antibiotic biosynthetic gene clusters.
In this report, we determined further sequence of the balhimycin biosynthetic gene cluster and thereby identified besides others a regulatory gene. We characterized the StrR-like pathway-specific regulator, Bbr, in order to determine its role in balhimycin biosynthesis.
Results

Completion of the Balhimycin Biosynthesis Gene Cluster and Analysis of the Newly Identified Open Reading Frames (ORFs)
The major part of the balhimycin biosynthesis gene cluster has been identified, sequenced and characterized as shown by Pelzer et al. [1999] and Recktenwald et al. [2002] . After assigning functions to all identified genes and proposing the biosynthetic pathway for balhimycin, two questions remained open: Since no regulatory gene was found so far, how is the expression of these complex biosynthetic steps coordinated? Where are the borders of the balhimycin biosynthesis gene cluster?
In order to find adjacent cosmids overlapping with the previously identified cluster sequence on the 'left' border and to define the borders of the balhimycin biosynthesis gene cluster, an appropriate DNA probe for hybridization against available cosmid pools of the balhimycin producer was designed. To avoid cross-hybridization, primers were designed (primer Ris1 and Ris2; table 1 ) from a non-conserved area of the bpsA gene, encoding a non-ribosomal peptide synthetase (NRPS). Through Southern hybridization as well as direct polymerase chain reaction (PCR) screening of cosmid pools, we isolated two adjacent cosmids, 4.3 and 55.1 (see In order to define the right border of the balhimycin biosynthesis gene cluster, Cosmid 16.1 (see table 1 ), which has been partially sequenced previously and contains a major part of the sequenced balhimycin biosynthesis gene cluster, was further sequenced and analyzed. This resulted in the identification of a new gene dahp (see fig. 5 ) , the product of which is significantly similar to a 3-deoxy-D -arabino-heptulosonate 7-phosphate (DAHP) synthase from Amycolatopsis methanolica ( table 3 ) .
Downstream of dahp, a gene which encodes for a protein with 40% identity on amino acid level to a type I polyketide synthase of the rifamycin producer A. mediterranei, was found, indicating that this gene is not part of the balhimycin biosynthesis gene cluster.
Two Regulatory Genes Are Present in the Balhimycin
Biosynthesis Gene Cluster From the analysis described above, two regulatory genes were identified in the balhimycin biosynthesis gene cluster.
One of the regulatory proteins, VanR, consists of 225 amino acids and is significantly similar to putative twocomponent system response regulators with highest homology to the putative two-component system response regulator from S. coelicolor A3(2) ( table 3 ) and may be involved in resistance: VanR homologs are present in resistant pathogenic bacteria [Arthur and Courvalin, 1993] and a S. coelicolor homolog is induced by various glycopeptide antibiotics [Hutchings et al., 2006] .
The second regulatory protein, Bbr, consists of 321 amino acids and shows significant similarity to putative transcriptional activators with 47% identity on an amino acid level (over a length of 289 amino acids) to StrR, the well-characterized pathway-specific regulator for streptomycin biosynthesis, in S. glaucescens [Beyer et al., 1996] and S. griseus [Distler et al., 1987] . Bbr shows the characteristic HTH motif commonly found in DNA-binding regulatory proteins. The HTH motif is located from amino acid 183 to 204 of Bbr (based on HTH prediction by the Dodd-Egan method [Dodd and Egan, 1990] ).
In silico Approaches to Determine Bbr-Binding Sites within the Balhimycin Biosynthetic Gene Cluster
Based on the previously published palindromic sequence of StrR-binding site [Retzlaff and Distler, 1995] GTTCGActG(N) 11 CagTcGAAC, in silico nucleotide sequence analysis was carried out to find inverted repeat sequences within the balhimycin biosynthetic gene cluster which might be targets for Bbr binding. However, an identical palindromic sequence could not be identified. Applying PatScan software, the sequence available for the balhimycin biosynthetic gene cluster was scanned in order to identify inverted repeat sequences allowing mismatches and various lengths of non-conserved spacers. Table 1 . List of primers used for this study. The names of the primers are indicated on the left. The primer sequence is 5 to 3
Primers used for detection of adjacent cosmids
Primers used for Bbr purification Ris 1;CAAGGCTGAGTTCGACGACGATTCC bbrHIS1;GGAGATCTGCCGCAAAGTTGACGAAGTAGATCC Ris 2;ACTGCCGTTTCTGCAACTCCGCCAG bbrHIS2;GGAGATCTCCGTGGTCACGCGATCATC
Primers used for band shift experiments Primers used for band shift experiments (continued) vanS-PROM1;ACCAGGACGGACCGCTCCAG
hmaS-PROM1;AACGGGAGCCGGCCTGGTTG vanS-PROM2;CGTTCCGCCGCGAGGTCTAC hmaS-PROM2;AGGTGAACGTGGCCGCCTCG vanR-PROM1;GACGGCGATGTCGTAGG orf7-PROM1;TCGCCGCCGAACTCCGGAAC vanR-PROM2;AATCCGGCGGGTCGTC orf7-PROM2;CCGCGGCAAAGGTGTGCAGC bbr-PROM1;CTGCCGTCCGGGGAATCGCG orf7-PROM1insi;ACCTGCCGGTGGTGCTCAAG bbr-PROM2;CTAGCCCCCATTTGGATCTAC orf7-PROM2insi;AACACCTGCCGGACGCCCTC pdh-PROM1;TCGCGTGACCACGGCGGAGCC dvaA-PROM1;GCGGTGCCTGCCGCTATCTTG pdh-PROM2;CGTTCCTTCTTAAAACGGCTCAC dvaA-PROM2;ACGTCCTCGGTCCGCATGTG tba-PROM1;GCCGGCCGCAAAAACGATTGC dvaA-PROM1insi;TGATGGCGTCGCCGATCCTG tba-PROM2;CCGGTCACCTCTCTCACACGC dvaA-PROM2insi;ACGTCCTCGGTCCGCATGTG bpsA-PROM1;AGGCCGACCAGATCCTCGTG dpgA-PROM1;TACGCCACCTGCCTGGAG bpsA-PROM2;CGAGCTGCCGGTACGTCAGAAC dpgA-PROM2;GCGGGTTCGATGCTGGTC bpsC-PROM1;GGCGGTGATCGTCCAGGAAC dpgA-PROM2insi;TCGCTCCCGCCGACTTCAGG bpsC-PROM2;TCGAGGGCGGTGTGATAGAG dpgA-PROM1insi;GGGTTGCTGCCGGACTACGC oxyA-PROM1;GAAGCGGGCCGTCAGGAGTGC dvaD-PROM1;AGGCGTACGACATCCACTTG oxyA-PROM2;TGCACAAGGTCCTTTCGCCTC dvaD-PROM2;GGGCACAGTAGACGTACTTG oxyB-PROM1;ACTGGCCGAGATGGTGTTC dahp-PROM1;GGTCTGGACCGGGGAATAC oxyB-PROM2;CGGGTCGTCATCATTCAA dahp-PROM2;GGTGACCAGGGGGACGAT oxyC-PROM1;ACCGGGGGCCCGCGACGTCCACGC oxyC-PROM2:CATCCGCGTGGAAACTCCTTGGTC Primers used for RT-PCR experiments bhaA-PROM1;GGTTCCGGTCACCTGGTAGC bbr-RT;GTGGAACACCCTGCAGGATC bhaA-PROM2;CTCCCACCATTCCTCTGTCG bbr-expra1;CAGGTGCTCGACGGCCTGCACCGGTTGAAG bgtfA-PROM1;CAGGTGCAGATGAAGGCGCTG bbr-expra2;CCCGTCCATGGAGTGCATGGTGAGCATGCG bgtfA-PROM2;TTCGCACCCTCTGTTCCGTAG oxyA-RT;GATGTCGAACTCGTCCTCCG bgtfC-PROM1;AACCACACCGGGTCGGCG oxyA-expra1;GCTTCCTCAACCAGTACGACCCCCCGGAGC bgtfC-PROM2;GCAAACGGTTCGACGTCTCCA oxyA-expra2;GAGCTGATCACCGATGCGCACGTCCTCCTG dvaC-PROM1;GCACCGACGGGACGACGATG bhp-RT;GCTTCTCCAGGTAGCCGAAG dvaC-PROM2;CGGTGGCAAGGCGGAAGAAG bhp-expra1;GGTGTGGGACCTGCACCAG orf2-PROM1;CGGTCAGTGGATCCTTTACG bhp-expra2;GCTTCTCCAGGTAGCCGAAG orf2-PROM2;CCGGCACCGAAGGAAAGAAC hrdB-RT;ACAGCGTCTGCAGCACCGAC bmt-PROM1;ACGACCTGGCCGGTTGTCTC hrdB-expra1;GAGGGCAACCTCGGTCTGATCCGCGCGGTG bmt-PROM2;CCTGGATCAGGTCCCGATAG hrdB-expra2;AGCGTCTGCAGCACCGACTGGAGCTGGTCC bhp-PROM1;TTCCATACGCCGCCGAGGTGTC bhp-PROM2;GAAGGTCCTCCCCTGCCCGC Alignment of the inverted repeat sequences found in putative promoter regions revealed the presence of a conserved palindromic motive in the upstream regions of bbr , tba , oxyA , dvaA and orf7 with one base pair mismatch, and in the upstream region of dpgA with two base pairs mismatch ( fig. 2 ) .
Overexpression of bbr in Escherichia coli and Purification of the Protein by Affinity Chromatography
To determine whether Bbr is a DNA-binding protein and whether the predicted in silico DNA-binding sites within the balhimycin biosynthetic gene cluster are true targets, Bbr was first overexpressed in E. coli and purified.
bbr from A. balhimycina was amplified by PCR with the corresponding primers (see table 1 ), cloned and expressed in E. coli under the control of the T7 promoter using the vector pRSETB. The N-terminal His 6 -tagged Bbr was purified using nickel affinity chromatography. The apparent molecular weight of Bbr is about 37 kDa (calculated mass 35.324 kDa) as determined by SDS-PAGE analysis ( fig. 3 ) 3 , lanes 5 + 6) was used for gel retardation analysis. The protein yield of these fractions was about 0.2 mg/ml.
Bbr Has DNA-Binding Activity and Targets Several Promoter Regions of the Balhimycin Biosynthetic Gene Cluster
The purified His 6 -tagged Bbr was used to determine the DNA-binding activity of Bbr by gel retardation assays. Digoxygenin (DIG)-labeled DNA fragments (100-200 bp upstream of predicted start codons) amplified via PCR from all upstream regions of coding sequences within the balhimycin biosynthetic gene cluster were used as probes.
The specificity of Bbr binding was confirmed by controls using 10-and/or 100-fold unlabeled competitor DNA of the corresponding probes as well as non-specific Streptomyces plasmid DNA. Unlabeled DNA fragments of the investigated putative promoter regions compete with the corresponding DIG probes for binding to His 6 -tagged Bbr, whereas there is no competition in case of the non-specific Streptomyces DNA. In one case the protein was boiled for 10 min prior to incubation with the bbr probe thus denaturing Bbr and affecting its binding to the DNA probe ( fig. 4 a) .
Analysis of gel retardation assays revealed that Bbr specifically binds to the upstream regions of the regulator gene bbr , the putative ABC transporter gene tba , the P450 monooxygenase gene oxyA , a gene involved in the dehydrovancosamine synthesis dvaA , and the putative sodium-proton anti-porter gene orf7 ( fig. 4 a, 5 ) . No binding was observed to the upstream regions of the [Retzlaff et al., 1995] . NRPS genes bpsA and bpsC , the P450 monooxygenase genes oxyB and oxyC , the halogenase gene bhaA , the glycosyltransferase genes bgtfA and bgtfC , a gene involved in the biosynthesis of the dehydrovancosamine sugar dvaC , a gene with unknown function orf2 , the methyltransferase gene bmt , the hydrolase gene bhp , the hydroxymandelate synthase gene hmaS , the dihydroxyphenylglycine synthase gene dpgA , and the DAHP synthase gene dahp (only one representative example of these results is shown in figure 4 b; summary of results in figure 5 ).
Analysis of bbr Expression in Relation to Balhimycin Production
The temporal transcription pattern of bbr and of some biosynthetic genes ( oxyA , bhp and bhaA ) was analyzed in correlation to antibiotic production using reverse transcription (RT)-PCR. The onset of antibiotic production was 35 h after incubation assessed by bioassay.
RNA was isolated at different time points ( fig. 6 ) using the RNA isolation kit (Qiagen) and used to produce the corresponding cDNA. PCR was carried out using cDNA as template and the primers listed in table 1 . The gene encoding the major sigma factor ( hrdB ) of A. balhimycina was used as a positive control since it is constitutively expressed throughout growth [Puk, unpubl. data] . Negative controls were carried out under the same conditions using the isolated RNA as a template without reverse transcriptase. The RT-PCR experiments showed that the expression of bbr occurs simultaneously with that of the studied biosynthetic genes starting at least 8 h before the onset of antibiotic production ( fig. 6 ).
Discussion
Seven New Genes Have Been Identified in the Balhimycin Biosynthetic Gene Cluster
In this work the sequence of the balhimycin biosynthetic gene cluster was extended. The newly identified genes, tba , pdh , dahp , vanY , vanS and two regulatory genes, bbr and vanR , are expected to be involved in the biosynthesis, resistance or regulation of balhimycin.
pdh and dahp , the products of which are highly similar to prephenate dehydrogenases and DAHP synthases, respectively, might represent a link between primary and secondary metabolism through the shikimate-chorismate biosynthetic pathway and are most likely needed for the supply of hydroxyphenylpyruvate, a precursor which is required for the biosynthesis of the balhimycin nonproteinogenic amino acids. Tba is probably involved in balhimycin transport, since it is highly similar to transmembrane ABC (ATP-binding cassette) transporters. VanY may be involved in resistance, since it is highly similar to D,D -carboxypeptidases which contribute to vancomycin resistance by hydrolyzing the C-terminal D -Ala residue of peptidoglycan precursors [Arthur and Courvalin, 1993] . The VanS-VanR putative two-component regulatory system identified in our study may also be involved in conferring resistance to the balhimycin producer in a manner similar to the well-established vancomycin resistance cascade in pathogenic enterococci [Arthur et al., 1992] and in the non-pathogen S. coelicolor [Hutchings et al., 2006] .
From this study and combining previous sequence reports, a total of 66 kb sequence data was determined for the balhimycin biosynthetic gene cluster encoding 36 ORFs. One border of the balhimycin biosynthetic gene cluster has also been predicted. Sequence analysis of the right border downstream of dahp revealed a type I polyketide synthase of a rifamycin producer in A. mediterranei which could be part of another biosynthetic gene cluster located directly next to the balhimycin biosynthesis locus.
The vanR and vanS genes identified in this study are most likely to be part of the balhimycin biosynthetic gene cluster, since their homologs are located within the other glycopeptide gene clusters such as chloroeremomycin, dalbavancin, complestatin and teicoplanin gene clusters [Donadio et al., 2005] . Nevertheless, to determine the final definition of the left border of the balhimycin biosynthetic gene cluster, further sequencing of the area upstream of vanS is underway.
Bbr Binds Directly to the Promoter Region of the Balhimycin Biosynthesis Genes
Bbr, a StrR-like pathway-specific regulator, was identified and characterized in this study to determine a possible role in balhimycin biosynthesis. Functional studies of StrR like regulators have been limited to StrR [Beyer et al., 1996; Retzlaff and Distler, 1995] , KasT from the kasugamycin producer Streptomyces kasugaensis [Ikeno et al., 2002] and NovG from the novobiocin producer Streptomyces spheroides [Eustaquio et al., 2005] . Our DNA-binding studies with Bbr provide the first characterization of a regulator of biosynthesis genes for glycopeptide antibiotics. On amino acid level, Bbr is as similar to KasT and NovG (45% amino acid identity) as it is to StrR.
The putative NovG-binding site possesses a conserved palindromic structure with the sequence GTTCAA-CTG(N) 11 CRGTTGAAC, as determined recently by gel retardation analysis [Eustaquio et al., 2005] , which differs in two positions from the StrR-binding site consensus sequence [Retzlaff and Distler, 1995] . Identical inverted repeat sequences could not be identified within the balhimycin biosynthetic gene cluster. Sequence-specific binding of Bbr to five putative promoter regions in the gene cluster allowed the deduction of a StrR-related palindromic consensus sequence, GTCCAa(N) 17 TtG GAC. Even a mismatch by two bases abolishes the binding ability of Bbr experimentally as was shown for the inverted repeat sequence upstream of dpgA which was detected by in silico analysis.
Interestingly, the proposed palindromic sequence for Bbr-binding site is also conserved within other glycopeptide biosynthetic gene clusters [Donadio et al., 2005] . Comparison of the balhimycin biosynthetic gene cluster with the biosynthetic gene clusters of chloroeremomycin (cep), dalbavancin (dbv), A47934 (sta) and teicoplanin (tcp) revealed the presence of the suggested Bbr consensus sequence in the upstream region of the biosynthetic gene oxyA , the product of which is significantly homologous to P450 monooxygenases, in all five clusters. In addition, the same consensus sequence is found upstream of the gene encoding the StrR homologous regulator in cep, upstream of the response regulatory gene in tcp, upstream of a gene unique for dalbavancin biosynthesis and upstream of a homolog to bal orf2 from tcp [Donadio et al., 2005] . Furthermore, we have newly identified the Bbr consensus sequence upstream of the ABC transporter in sta and dbv clusters.
Operon Structures within the Balhimycin Biosynthetic Gene Cluster
Bbr binds upstream of bbr , tba , oxyA , orf7 and dvaA . Combining these results together with our previous reports on possible operon structures within the balhimycin biosynthetic gene cluster [Pfeifer et al., 2001; Puk et al., 2004] and with sequence analysis data, the following operon structures can be suggested for the balhimycin biosynthetic gene cluster ( fig. 5 ): the first operon comprises bbr and pdh ; the second operon comprises tba and all three NRPS genes together with the small orf1; the third operon covers the region from oxyA to bmt ; the fourth operon only consists of the divergent gene pgat; the fifth operon comprises the genes involved in the biosynthesis of ␤ -hydroxytyrosine, bhp , bpsD and oxyD [Puk et al., 2004] , as well as genes of the hydroxyphenylglycine biosynthesis, hmaS and hmO ; the sixth operon contains only orf7 , and the last operon expands from dvaA to dahp . As mentioned above, the proposal of these operon structures within the balhimycin biosynthetic gene cluster is based on either experimental data or sequence analysis revealing that the start (GTG) and stop (TGA) codons of the genes overlap with the sequence GTGA suggesting that these genes are most likely translationally coupled. All other intergenic regions were not targeted by the pathway-specific regulator Bbr. This implies that the respective genes are either co-transcribed with upstream genes, which are targeted by Bbr, or regulated via a different mechanism which has not yet been characterized.
The divergent genes at the core of the balhimycin biosynthetic gene cluster suggest that the intergenic region between bhp and pgat might contain a promoter. However, the proposed palindromic sequence for Bbr-binding site could not be identified within this intergenic region and no binding of Bbr was observed in gel retardation assays. The fact that Bbr does not bind to the promoter region of bhp -pgat , genes which are involved in the biosynthesis of balhimycin precursors, leads to the assumption that these genes are regulated via a different mechanism which is still elusive.
Concluding Remarks
The putative two-component regulatory system genes vanR and vanS identified in our study may be part of a resistance cascade similar to that of vancomycin [Arthur et al., 1992] . As Bbr did not bind to the promoter regions of either gene, it seems likely that resistance is controlled separately from the biosynthesis. Induction of resistance might be achieved through sensing the glycopeptide antibiotic by the histidine kinase VanS in analogy to the role of VanS in S. coelicolor [Hutchings et al., 2006] .
In S. griseus , the molecular mechanism by which a ␥ -butyrolactone microbial hormone, A-factor, triggers streptomycin biosynthesis is well established. A transcriptional activator AdpA switches on many genes required for both morphological development and secondary metabolism. AdpA binds to the promoter region of strR and activates its transcription. The pathway-specific transcriptional activator StrR then induces transcription of the streptomycin biosynthetic genes by binding multiple sites in the gene cluster, thus leading to biosynthesis of streptomycin [reviewed by Horinouchi, 2002; Tomono et al., 2005] . Whether balhimycin production is triggered by a similar regulatory cascade and the transcription of bbr is induced by an AdpA-equivalent activator still needs to be investigated.
Ongoing studies of the complex regulation of balhimycin production will deliver a comprehensive picture of the overall antibiotic biosynthesis. This will aid in the genetic manipulation of the biosynthetic gene cluster and will help obtain new compounds to combat the sharply increasing antibiotic resistance.
Experimental Procedures
Bacterial Strains and Plasmids
The strains and plasmids used for this study are listed in table 2 .
Media and Culture Conditions E. coli strains were grown in Luria broth medium [Sambrook et al., 1989] supplemented with 100 g of ampicillin ml -1 or 100 g of apramycin ml -1 when necessary to maintain plasmids. A. balhimycina strains were grown in R5 medium [Kieser et al., 2000] at 30 ° C. Liquid and solid media were supplemented with 50 g ml -1 of apramycin to select for strains carrying integrated antibiotic resistance genes.
DNA Preparation, Manipulations and Hybridization
The methods used for the isolation and manipulation of DNA for E. coli and actinomycetes were described by Sambrook et al. [1989] and Kieser et al. [2000] , respectively. PCR fragments were Shawky /Puk /Wietzorrek /Pelzer / Takano /Wohlleben /Stegmann isolated from agarose gels with a QIAquick kit (Qiagen, Hilden, Germany). Restriction endonucleases were obtained from various suppliers and were used according to their specifications. Southern hybridization was carried out as previously described [Pelzer et al., 1999] .
PCR Protocols
PCR was performed with a programmable thermal controller (MJ Research, Inc.). Each PCR mixture (100 l) contained 100 pmol of each primer, 1.0 g of template DNA (cosmid 16.1 or cosmid 55.1), deoxyribonucleoside 5 -triphosphates at a final concentration (each) of 20 M (DNA polymerization mix; Pharmacia), 10 ! reaction buffer (Qiagen), 5 ! Q-solution (Qiagen), and 3.5 U of Taq DNA polymerase. Dimethyl sulfoxide (Stratagene) was added to the reaction mixture at a final concentration of 3% to enhance the specificity of hybridization. For amplification of the DNA fragments, the following PCR conditions were used: initial denaturation (95 ° C for 2 min); 25 cycles of denaturation (95 ° C for 30 s), annealing (52 ° C for 30 s), and polymerization (72 ° C for 30 s), and an additional polymerization step (72 ° C for 7 min) at the end. The primers used are listed in table 1 .
Expression and Purification of His 6 -Tagged
Bbr bbr from A. balhimycina was amplified by PCR with the primers bbrHIS1 and bbrHIS2 ( table 1 ) that include Bgl II and Hin dIII sites, and cloned in pJOE890 Sma I blunt end. Then bbr was cloned into the expression vector pRSETB (Invitrogen) Bam HI/ Hin dIII to generate an in-frame fusion with the His 6 -tag (T7 promoter). His 6 -tagged Bbr was expressed in E. coli BL21(DE3)pLysS cells and purified with nickel (II)-nitrilotriacetic acid (Ni-NTA) spin columns (Qiagen) at 4 ° C as described in the Ni-NTA Handbook (Qiagen). The starting point of purification was the soluble protein fraction of a 50-ml expression culture (induced with 1 m M IPTG/37 ° C) obtained after French Press and centrifugation of the cell lysate.
Protein Analysis
Protein concentrations were determined by the Bradford method [Bradford, 1976] using bovine serum albumin as a standard. SDS-polyacrylamide gel electrophoresis was carried out according to the method of Laemmli [1970] , and protein bands were stained with Coomassie Brilliant Blue G-250.
Preparation of 3 -End DIG-Labeled DNA Fragments DNA fragments were amplified from the upstream regions of almost all genes of the balhimycin biosynthetic gene cluster. Primers used for amplification of the DNA fragments are listed in table 1 ; each primer pair carries the name of the corresponding gene. After purification, the 3 -end DIG-11-ddUTP labeling of the DNA fragments was carried out using DIG Gel Shift Kit, 2nd Generation (Roche Molecular Biochemicals) according to the manufacturer's instructions.
Gel Retardation Assays
Gel retardation assays were performed using the DIG Gel Shift Kit, 2nd Generation (Roche Molecular Biochemicals) according to the manufacturer's instructions. 3 ng of DIG-labeled DNA fragment and approximately 0.2 g of partially purified His 6 tagged Bbr, fraction eluted with 200 and 500 m M imidazole, were used for each assay. For testing the specificity of binding, competitor plasmid-DNA or corresponding unlabeled DNA fragment were added in approximately 100-fold molar excess in comparison to the labeled fragment. After 15 min of incubation, the reaction mixture was applied to a native polyacrylamide gel with 1 ! TBE [Sambrook et al., 1989 ] as running buffer. The gel was run at 80 V for about 2 h, and transferred to a positively charged Hybond-N+ nylon membrane (Amersham Biosciences) by contact blotting. Cross-linking and detection were carried out following the manufacturer's instructions.
Bioassay for Detection of Active Balhimycin
Balhimycin production was determined by bioassays using Bacillus subtilis ATCC6633 as test organism and cell supernatants of Amycolatopsis strains [Pelzer et al., 1999] .
Preparation of A. balhimycina RNA A. balhimycina was cultivated in 100 ml of R5 medium for 10-49 h. The cells were then harvested and shock frozen at -70 ° C. An aliquot was resuspended in 100 l of P buffer [Thompson et al., 1982] containing 10 mg of lysozyme and then incubated for 7 min at 37 ° C. The RNA was extracted by use of an RNeasy mini kit (Qiagen) according to the manufacturer's instructions.
RT-PCR Analysis
RNA prepared from A. balhimycina was treated with 3 U of RNase-free DNase I (Promega, Madison, Wisc., USA) and precipitated according to standard protocols [Sambrook et al., 1989] . The RNA concentration was photometrically determined with a Genequant fixed-wavelength photometer (Pharmacia, Freiburg, Germany). Reverse transcription (RT) reactions were performed by use of an Omniscript RT kit (Qiagen) according to the manufacturer's instructions. The primers used for RT reaction are listed in table 1 . PCRs were carried out in a programmable thermal controller (MJ Research, Inc., La Jolla, Calif., USA) under the following conditions: initial denaturation (95 ° C for 2 min); 25 cycles of denaturation (95 ° C for 20 s), annealing (60 ° C for 30 s), and polymerization (72 ° C for 40 s), and finally, an additional polymerization step (72 ° C for 7 min). Each PCR mixture (25 l) contained a 1-l aliquot of RT reaction product, 100 pmol of each primer, deoxyribonucleoside 5 -triphosphates at a final concentration (each) of 20 M (DNA polymerization mix; Pharmacia), 10 ! reaction buffer (Qiagen), 5 ! Q-solution (Qiagen), and 3.5 U of Taq DNA polymerase (Qiagen). The PCR products were analyzed by agarose gel electrophoresis (1.0%). Primers used for amplification are listed in table 1 .
Computer-Assisted Sequence Analysis
The PatScan software [D'Souza et al., 1997] and the BLAST program [Altschul et al., 1990] were used for analysis of inverted repeat patterns and for homology searches in the GeneBank database, respectively.
Nucleotide Sequence Accession Number
The nucleotide sequences of the balhimycin biosynthesis genes reported in this paper are available from the EMBL data library under accession number Y16952.
